Chunghwa Chemical Synthesis & Biotech Co. Ltd. | |
Stock Exchange | Taiwan Stock Exchange |
EPS |
TWD3.47 |
Market Cap |
TWD2.75 T |
Shares Outstanding |
77.56 M |
Public Float |
- |
Address |
No. 1 Dongxing Street New Taipei TP 238 50 Taiwan |
Employees | - |
Website | http://www.ccsb.com.tw |
Updated | 07/08/2019 |
Chunghwa Chemical Synthesis & Biotech Co., Ltd. engages in the manufacture of active pharmaceutical ingredient (API). Its products include pain management for skeletal muscle pain and migraine, immunosuppressant for reducing immune activity after organ transplant, antifungal such as fluconazole,caspofungin and micafungin, oncology that act against cancers, and other APIs for lowering cholesterol and anti diabetic drugs. The company was founded on May 19, 1964 and is headquartered in New Taipei, Taiwan. |